摘要
用重组人类红细胞生成素（ｒＨｕＥＰＯ）治疗血液透析贫血患者６７例。治疗３年后患者的血红蛋白（Ｈｂ）及红细胞比积（Ｈｔ）均较３年前明显增高；血清铁和血清铁蛋白较３年前降低；收缩压、舒张压及心胸比值则无明显变化。提示长期使用ｒＨｕＥＰＯ能有效地改善血透患者的贫血状态，但同时也导致缺铁。
ecombinant human erythropoietin(rHuEPO)was
given for 3 years to 67 hemodialysispatients with anemia. Hemoglobin and hematocrit were
significantly higher,but serum ironand ferritin were significantly lower than those of the pre-
treatment level.There was no sig- nifioant change in blood pressure and CTR.Antihypertensive
drugs were required in 32 pa- tients. It is concluded that long- term treatment of rHuEPO is
effective to anemic hemodiayl- sis.
出处
《湖南医科大学学报》
CSCD
1995年第6期599-600,共2页
Bulletin of Hunan Medical University
关键词
红细胞生成素
贫血
血液透析
erytbropoietin
anemia
hemodialysis
therapeutic
use
